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  Abstract 
 
Abstract 
Most vertebrates depend on an uninterrupted supply of oxygen to maintain the energy 
production. Some species, like the crucian carp (Carassius carassius) can survive hypoxia for 
an extended period. This fish is an expert in acquiring the little oxygen that exists in hypoxic 
water, and can boost its anaerobic ATP production by up-regulating the glycolysis and 
convert lactate to ethanol.  
Angiogenesis, the formation of new blood vessels, is induced by hypoxia and 
controlled through several factors. One of the most important hypoxia driven transcription 
factors, the hypoxia-inducible factor (HIF)-α, has been found to play a major role in 
coordinating many adaptive responses to hypoxia. It is continuously synthesized and degraded 
in normoxic conditions, but accumulates at low oxygen tension. Several factors control the 
expression of HIF-α, among them the factor-inhibiting HIF-1 (FIH-1). One mechanism by 
which HIF-α mediates increased oxygen delivery is through inducing the expression of 
vascular endothelial growth factor (VEGF), which in turn stimulates the formation of blood 
vessels.  
In this thesis mRNA levels of HIF-1α, HIF-2α, FIH, VEGFA, VEGFC and VEGFD 
were quantified by real-time RT-PCR in brain tissue from the crucian carp exposed to 
hypoxia. The effect of hypoxia on vascular density in crucian carp brain was also studied. 
A significant increase in mRNA levels was seen in both VEGFA and VEGFC, while 
no change was seen in VEGFD. VEGFA increased 6-fold and constituted the largest part of 
the quantified VEGF expression. Different splice isoforms of VEGFA have previously been 
characterized in mammals and fish, and two of these splice isoforms were cloned in the 
crucian carp, VEGFA121 and VEGFA165. A trend towards a reduction in VEGFD expression 
was observed in hypoxia, which may indicate that it does not have the same function in 
angiogenesis in crucian carp as VEGFA and VEGFC. 
The expression level of FIH increased 4-fold in hypoxia. No changes in mRNA levels 
were seen in either HIF-1α or HIF-2α, but a trend towards reduction was seen in HIF-1α. The 
increase seen in VEGFA and FIH indicates that the fishes have been hypoxic. This might 
imply that the expression of HIF-α also increases, but in order to verify this protein analyses 
would have to be performed to verify this.  
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Regarding blood vessel density two parameteres were measured, blood vessel surface 
area per unit volume and blood vessel length per unit volume. A significant decrease was seen 
in both of these parameters. The increase in VEGFA expression along with a reduction in 
blood vessel density can indicate that the hypoxic crucian carp does not require additional 
blood vessels during hypoxia, but instead suppresses global HIF-α effects, which may work 
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Most vertebrates depend on continous oxygen supply for fundamental processes such 
as energy production. How organisms tolerate conditions of limiting oxygen supply (hypoxia) 
to cells and tissues vary widely among species (Hochachka and Lutz, 2001). An important 
factor is where they live. Living in water increases the possibility of encountering hypoxia, 
primarily because the amount of oxygen contained in a given volume of water is only 1/30th 
of the amount contained in the same volume of air. Further, the rate of diffusion of oxygen in 
water is 10 000 times slower than in air (Nilsson and Renshaw, 2004). The crucian carp 
(Carassius carassius) often lives in small ponds, and during winter the water becomes anoxic 
since photosynthesis is blocked due to the ice cover (Nilsson and Renshaw, 2004). 
Vertebrates that live in habitats where hypoxia is regularly encountered have evolved 
physiological and behavioural mechanisms to cope with such challenges. The best studied 
examples of anoxia-tolerant vertebrates are the crucian carp and some species of North 
American freshwater turtle, particulary Trachemys scripta and Chrysemys picta (Nilsson and 
Lutz, 2004). The turtles have evolved their anoxia tolerance in response to overwintering in 
anoxic mud at the bottom of lakes. While turtles are comatose during anoxia, the crucian carp 
stay active (Nilsson, 2001). This allows the crucian carp to move to oxygen rich locations or 
the water surface to gulp air. 
 
1.1 Physiological adaptations to anoxia in the crucian carp   
The crucian carp has several strategies for coping with low oxygen supply. It is an 
expert in acquiring the little oxygen that exists in hypoxic water. For instance, the 
haemoglobin of the crucian carp shows an extreme high affinity for oxygen (Sollid et al., 
2005). 
An impressive quality of the crucian carp is the ability to change the morphology of 
the gills to increase the respiratory surface area approximately 7.5 times when exposed to 
hypoxia (Sollid et al., 2003). The respiratory units of the fish, its gill lamellae, becomes 
protruding after 7 days in hypoxic water due to apoptotic death of cells that cover much of the 
lamellar surface during normoxia (Sollid et al., 2003). 
The capacity for anoxic survival is extended over a wide temperature range. At 
temperatures close to 0°C the crucian carp can survive anoxia for several months, while at 
room temperature it can tolerate anoxia for at least a day or two (Nilsson and Lutz, 2004). 
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Providing sufficient amounts of ATP for cellular processes is a major challenge at low 
oxygen accessibility. During hypoxia, oxidative phosphorylation stops, and leaves the cell 
with glycolysis as the only major ATP producing process (Nilsson, 2001).  
In crucian carp, the brain blood flow rate more than doubles during anoxia and 
remains elevated for the entire anoxic period (Nilsson et al., 1994). A similar increase in 
blood flow also occurs in the anoxic freshwater turtle brain (Hylland et al., 1994), but in this 
situation the increase is only temporary, and the blood flow starts to fall back to pre-anoxic 
values within 100 minutes as the turtle enters its comatose state. The increased blood flow is 
thought to be needed to supply glucose to the brain (Lutz and Nilsson, 1997). 
Lactate is the end-product of anaerobic ATP production for all vertebrates. However, 
genus Carassius (Johnston and Bernard, 1983; Shoubridge and Hochachka, 1980). Fishes 
produce ethanol as the major glycolytic end-product during severe hypoxia and anoxia. By 
releasing the ethanol to the water through the gills by diffusion, the crucian carp avoids the 
problem of self-intoxication and end-product build-up, and the high lactate levels and 
consequent acidosis faced by other vertebrates. The ability to produce ethanol allows 
Carassius to maintain a high glycolytic rate for long periods without having to suffer from 
enormous lactate loads- an opportunity that is not available to the turtle (Lutz and Nilsson, 
1997).  
Surviving severe hypoxia/anoxia based on glycolytically produced ATP is 
energetically very costly, so the crucian carp is dependent on its glycogen stores (Nilsson, 
1990). It is known that the crucian carp has the largest store of glycogen of any vertebrate 
(Lutz and Nilsson, 1997). 
It is important to keep in mind that the crucian carp is well-adapted to survive hypoxia 
or anoxia. This situation is opposite to that in the mammalian brain, where death is the norm 
in anoxia. Any experimental attempts to extend anoxic survival by boosting or blocking a 
particular mechanism in a mammal are likely to be hampered by failures of other functions. In 
mammals, anoxia is synonymous with catastrophe, and a major problem with studying the 
anoxic mammalian brain is that the physiological changes are very rapid and complex, 
making it extremely difficult to sort out damaging events from useful defense mechanisms 
(Nilsson and Lutz, 2004). 
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1.2 Angiogenesis 
Hypoxia induces multiple systemic responses including angiogenesis, erythropoiesis 
and glycolysis (Haddad, 2002). When hypoxic exposure is prolonged for more than a day or 
so, the increase in cerebral blood flow (CBF) becomes attenuated (Xu et al., 2004), so that by 
three weeks of hypoxia exposure the CBF has returned to the prehypoxic baseline. One 
possible reason for the renormalization of CBF is the observation that the packed red cell 
volume increases with exposure to hypoxia (Lenfant and Sullivan, 1971). This means that the 
oxygen content of the circulating blood has been restored by balancing the loss of oxygen 
with increased carrier, so that the oxygen delivery can be restored at the prehypoxic blood 
flow rate (Shi et al., 2006). Blood hematocrit has been shown to increase in mammals (Drew 
et al., 2004). Brain blood flow has also been shown to increase in hypoxic crucian carp 
(Nilsson et al., 1994). 
One of the most important hypoxia driven factors, the hypoxia-inducible factor (HIF)-
1α, plays a major role in coordinating many adaptive responses to hypoxia in mammals (Lutz 
and Nilsson, 2004). In order to respond rapidly to hypoxia, cells continously synthesize, 
ubiquitinate and degrade HIF-1α under normoxic conditions (Hirota and Semenza, 2006). 
When the oxygen level drops, this protein escapes degradation and accumulates. 
HIF-1α is an important mediator for increasing the efficiency of oxygen delivery 
through inducing the expression of vascular endothelial growth factor (VEGF), which in turn 
stimulates the formation of blood vessels. A well-controlled process of adaptations to hypoxia 
enables oxygen to be delivered more efficiently, through upregulation of VEGF and the 
expression and activation of other mechanisms such as glucose transporters and glycolytic 
enzymes (Haddad, 2002). 
In mammals almost every cell is located within 50-100 μm of a capillary to ensure 
adequate oxygen supply (Alberts B. et al., 2002). What mechanism ensures that the system of 
blood vessels ramifies into every corner? It is endothelial cells that respond to signals 
produced by the tissue that they invade. A shortage of oxygen in the cells causes an increase 
in the intracellular concentration of HIF-α, which stimulates transcription of VEGF, and leads 
to angiogenesis. Angiogenesis is the growth of new blood vessels from pre-existing vessels. 
In a healthy body it is needed for restoring blood flow to tissues after injury or insult. In 
females, angiogenesis also occurs during the monthly reproductive cycle and during 
pregnancy (Ferrara et al., 2003). 
                                                                                                                                                  11 
  Introduction 
 
Angiogenesis is controlled through several factors. These can be grouped into the “on-
switches” including hypoxia-inducible factor 1 and 2 (HIF-1 and -2), and “off-switches” 
including factor inhibiting HIF (FIH). There is a continous balance between the on-switches 
and off-switches, and generally angiogenesis is turned off due to the production of more 
inhibitors than stimulators.  
Angiogenesis is essential for several pathological conditions. If the formation of blood 
vessels is disregulated, this can contribute to numerous malignant, ischemic, inflammatory, 
infectious and immune disorders (Carmeliet, 2003). Both HIF and VEGF are upregulated in a 
number of diseases, making them interesting targets for angiogenesis inhibition as a 
therapeutic strategy (Ho and Kuo, 2007). Therefore, an anti-VEGF strategy is currently being 
used in various clinical trials to treat tumour patients with the aim of inhibiting tumour-
induced angiogenesis, thereby depriving the tumor cells of nutrients and oxygen (Korsisaari et 
al., 2007). Thus research on angiogenesis and the factors involved has attracted considerable 
attention recently.  
 Lymphangiogenesis results in the formation of a vascular network distinct from 
arteries and veins that serves to drain interstitial fluid from surrounding tissues (Kuchler et al., 
2006). It plays a pivotal role in immune responses, since leukocyte traffic via the lymphatic 
vessels to lymph nodes is essential for antigen presentation, and in cancer biology, since 
tumor cells can spread via the lymph- and blood vessels to establish distant metastases 
(Baldwin et al., 2005). In mammals, lymph vessels are lined by endothelial cells possibly 
sprouting from embryonic veins, and their development appears to be critically dependent on 
the function of PROX1 (a homeobox gene and a specific marker of a subpopulation of 
endothelial cells) (Wigle and Oliver, 1999) and on VEGFC signalling (Karkkainen et al., 
2004). 
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1.3 Hypoxia inducible factor (HIF) 
HIF is a transcription factor, and is a main regulator of gene expression in response to 
hypoxia. It consists of an α- and a β-subunit. There are three types of α-subunits,  HIF-1α, 
HIF-2α and HIF-3α (Ratcliffe, 2007), of which HIF-1α is the best characterized. In contrast 
to HIF-1α and HIF-2α, HIF-3α has more restricted expression patterns. HIF-1α and HIF-2α 
show a 48% amino acid sequence similarity, they are both hypoxia-induced and they have 
overlapping expression pattern (Hu et al., 2003). To function as transcription factors, both 
HIF-1α and HIF-2α need to form a dimer with HIF-β, also known as aryl hydrocarbon 
nuclear translocator (ARNT). The dimers, named HIF-1α and HIF-2α, bind to DNA and 
upregulate the expression of a largely shared group of target genes. In addition to the amino-
terminal basic helix-loop-helix (bHLH) and Per-ARNT-Sim homology (PAS) domains, the 
HIF-α`s possess two transactivation domains (TADs), separated by a region termed the 
inhibitory domain (ID), which is responsible for normoxic repression of TAD activity. 
Overlapping the amino-terminal TAD (N-TAD) is an oxygen-dependent degradation domain 
(ODDD), which confers normoxic instability to the HIF-α proteins (Bracken et al., 2003) 
(figure 1.1). 
It was proposed earlier that HIF-1α is ubiquitously expressed, while HIF-2α is 
detected in vascular endothelial cells where it activates the transcription of VEGF (Elvert et 
al., 1999). Later it has been shown that HIF-2α is involved in the expression of other genes as 
well (Gordan et al., 2007; Hu et al., 2003). 
 
 
Figure 1.1. HIF-1α, HIF-2α and ARNT (HIF-1β) domain structure. HIF-1α, HIF-2α and ARNT are basic helix-
loop-helix/Per-ARNT-Sim homology (bHLH/PAS) transcription factors. In addition to the carboxy-terminal 
transactivation domain (C-TAD), similar to ARNT, HIF-1α, HIF-2α also possess an additional amino-terminal 
transactivation domain (N-TAD), an inhibitory region (ID) that negatively TAD activity and an oxygen-
dependent degradation domain (ODDD) that mediates oxygen-regulated stability. From (Bracken et al., 2003). 
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In contrast, HIF-3α may function as an inhibitor that is involved in the negative 
regulation of transcriptional responses to hypoxia (Hirota and Semenza, 2006).  
Gene expression mediated by HIF is oxygen sensitive, in part because HIF-α is rapidly 
degraded in normoxic conditions but stable in hypoxia (Sollid et al., 2006). In normoxia, HIF-
α is hydroxylated and recognized by the von-Hippel-Lindau protein, ubiquitinated and then 
degraded via the proteasomal pathway (Sollid et al., 2006). When the cells become hypoxic, 
the stabilized HIF-α enters the nucleus and dimerizes with ARNT. The dimers bind to HRE 
(hypoxia-responsive elements) in the promoter/enhancer region of the target genes, and 
thereafter interact with transcriptional co-activators.  
Activation of HRE leads to upregulation of several genes, including VEGF (Spike et 
al., 1998). In part, the oxygen sensitivity of HIF function is caused by oxygen-dependent 
hydroxylation of a spesific asparagine residue near the C-terminus of HIF-α. The asparagine 
residue is required for interaction with co-activator CBP/p300, which cannot occur if the 
amino acid is hydroxylated. This hydroxylation event is catalyzed by an asparaginyl 
hydroxylase, also known as factor-inhibiting HIF-1 (FIH-1) (figure 1.1).  
Thus, while the hydroxylation of two proline residues by prolyl hydroxylases (PHD2) 
earmarks the protein for degradation, FIH possesses an asparaginyl hydroxylase activity that 
by targeting Asn803 (HIF-1α ) or Asn851 (HIF-2α) (Stolze et al., 2004) represses HIF-α 
transcriptional activity by preventing binding of the transcriptional coactivator CBP/p300 to 
the HIF-α C-TAD (COOH-terminal transcriptional activation domain) (Dayan et al., 2006). 
Silencing of either PHD2 or FIH in normoxia partially induces hypoxic genes, whereas 
combined PHD2/FIH silencing generate a full hypoxic gene response. FIH does not influence 
HIF-α stability but allows for modulation of HIF-α transactivation (Dayan et al., 2006).   
In crucian carp, HIF-1α levels are affected by both oxygen and temperature. Rissanen 
et al. (2006a) showed that hypoxia initially increased the HIF-1α protein in all studied tissue 
at different temperatures except for liver at 18°C, but HIF-1α activity increased only in the 
heart of 8°C acclimated fish and in the gills of 18°C acclimated fish. They also found that 
HIF-1α mRNA levels at 8°C increased in the gills and in the kidney, and that it also increased 
at 26°C in the gills (Sollid et al., 2006). 
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Figure 1.2. Oxygen -regulated transcriptional activation of HIF-1α and HIF -2α. In normoxia, an oxygen 2-
oxoglutarate and iron- dependent HIF-α asparaginyl hydroxylase (FIH-1) binds and hydroxylates specific 
asparagine residues of HIF-1α (N803) and HIF-2α (N851). This blocks recruitment of transcriptional 
coactivators (CBP/ p300) by the carbox- terminal transactivation domain (C-TAD), resulting in transcriptionally 
inactive HIF-α. In hypoxia, FIH-1 activity is blocked due to oxygen deficiency, resulting in no asparagine 
hydroxylation, and consequently enhanced coactivator recruitment and target gene induction. Modified  from 
(Bracken et al., 2003). 
 
HIF-2α, but not HIF-1α, interacts with the NF-κB essential modulator (NEMO). NF-
κB is a dimeric transcription factor that was first identified as a factor which regulates the 
expression of the immunoglobulin κ light chains in B lymphocytes. It is also recognized as a 
sequence-specific transcription factor involved in the activation of a large number of genes in 
response to inflammation, viral and bacterial infections, and other stressful situations 
requiring rapid reprogramming of gene expression, such as oxidative challenge (Haddad, 
2002).  
The interaction between HIF-2α and NEMO enhances normoxic HIF-2α 
transcriptional activity, independently of the HIF-2α transactivation domain, consistent with a 
model by which NEMO aids CBP/p300 recruitment to HIF-2α. In contrast, HIF-2α 
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overexpression does not alter NF-κB signaling, suggesting that the functional consequence of 
the HIF-2α/NEMO interaction is limited to the HIF pathway. The specificity of NEMO for 
HIF-2α represents one of the few known differential protein-protein interactions involving 
HIF proteins, which has important implications for the activity of HIF-2α (Bracken et al., 
2003) 
Changes in HIF-1α most often occur at the protein level, but can also be seen at the 
mRNA level (Sollid et al., 2006; Wang et al., 1995). Sollid et al. (2006) have shown that the 
HIF-1α protein accumulates in the hypoxic crucian carp, and that the mRNA levels followed 
the protein level trend. 
 
1.4 Vascular endothelial growth factor (VEGF) 
VEGF was originally identified as an endothelial cell specific growth factor 
stimulating angiogenesis and vascular permeability, which is required for the growth and 
differentiation of endothelial cells (Byrne et al., 2005). More recent studies report that VEGF 
affects a number of other cell types too (e.g. monocytes, macrophages, neurons, cancer cells, 
kidney epithelial cells). VEGF was first described by Senger et al. (1983). Further 
characterization resulted in a publication describing some details of the protein (Senger et al., 
1986). However, the protein structure and amino acid sequence of this factor was not 
described until 1990 (Senger et al., 1990).  
The VEGF family plays a key role in angiogenesis. It is important in physiological 
conditions like endometrial growth, reproductive functions in adults etc. as well as in 
pathological conditions like diabetic retinopathy and tumor cell growth. It also has an 
important role in lymphangiogenesis (Roy et al., 2006b).  
VEGF has been shown to be of great importance during development, both in 
vasculogenesis and in angiogenesis. Deletion of either a single or both alleles of VEGF in 
mice results in embryonic lethality (Ferrara et al., 2003; Li et al., 2007), but overexpression of 
VEGF also leads to this. These results underline the importance of proper blood vessel 
formation (Maharaj and D'Amore, 2007). On the other hand, the function in normal adult 
tissue is poorly understood. In tissues characterized as having a barrier function like the brain 
(blood-brain barrier), relatively few cells express VEGF (Maharaj and D'Amore, 2007). 
                                                                                                                                                  16 
  Introduction 
 
HIF directly activates transcription of the VEGF gene (Cai et al., 2003). HIF binds to 
an HRE in the VEGF promoter region (Hirota and Semenza, 2006), and thereby upregulates 
VEGF trancription in hypoxia (Storkebaum et al., 2004).  
The human VEGF gene is located on chromosome number 6 and is organized in eight 
exons. (Ferrara et al., 2003). Expression of VEGF is stable in tissue that is angiogenic, but not 
in tissue like cerebellum, prostate, pancreatic islets and glomeruli (Woolard et al., 2004). 
In mammals, the VEGF family comprises seven secreted glycoproteins that are 
designated VEGFA, VEGFB, VEGFC, VEGFD, VEGFE, VEGFF and the placental growth 
factor (PIGF). The vascular endothelial growth factors exert their angiogenic role through        
their receptors which are located on the endothelial cells of blood vessels. These receptors are 
transmembrane tyrosine kinases which upon binding of their ligands to the extracellular 
domain of the receptor activate a cascade of downstream proteins (figure 1.3). The receptors 
involved are VEGF receptor-1 (VEGFR-1), VEGF receptor-2 (VEGFR-2), VEGF receptor-3 
(VEGFR-3) and the neurophilins (NRP-1 and NRP-2). The neurophilins lack tyrosine kinase 
activity and must therefore interact with other receptors to transduce signalling. It also 
appears that the receptors interact with each other in order to enhance signalling (Otrock et al., 
2007b). 
 
Figure 1.3. VEGF and its receptor. VEGF binding to its receptor leads to receptor dimerization and activation 
of receptor tyrosine kinases by autophosphorylation. This leads to several biological effects on endothelial cells. 
Modified from (Otrock et al., 2007b). 
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This thesis focuses on VEGFA, VEGFC and VEGFD, because VEGFA in mammals 
has been shown to be the most important in the family when it comes to angiogenesis, which 
is the emphasis of this thesis. VEGFC and VEGFD are involved both in angiogenesis and in 
lymphangiogenesis (Byrne et al., 2005). These are the reasons why this thesis focuses on 
VEGFA, VEGFC, and VEGFD. 
 
1.4.1 VEGFA 
VEGFA is a key molecule in the induction of angiogenesis and vasculogenesis (the 
process of blood vessel formation occuring by de novo production of endothelial cells), and it 
is the best characterized and most studied member of the VEGF family (Otrock et al., 
2007a).VEGFA mediates its responses primarily by activating VEGFR-1 and VEGFR-2, 
expressed in vascular endothelial cells, but it also binds to NRP-1 and NRP-2 which are 
expressed in vascular endothelium and neurons.  
In humans alternative exon splicing of the VEGFA gene results in at least 6 different 
isoforms, the most common being 121, 145, 165, 183, 189 and 206 amino acids long (Roy et 
al., 2006b). These isoforms have distinct but overlapping functions in VEGFA controlled 
angiogenesis due to their differential binding to VEGFA receptors. The VEGFA165 isoform is 
the most potent promoter of stimulating angiogenesis. Recently, an alternative variant of 
VEGFA165, VEGFA165b has been identified in mammals. This variant contains an alternative 
sequence in exon 8, encoding 6 amino acids. In contrary to all other VEGFA isoforms, 
VEGFA165b is an inhibitor of angiogenesis, counteracting VEGFA-induced proliferation and 
migration of endothelial cells (Byrne et al., 2005). Although the VEGFA gene structure and 
regulation are well characterized in human and mouse, no such information is available in 
fish. Two VEGFA isoforms have been found in zebrafish, VEGFA121 and VEGFA165 (Bahary 
et al., 2007). VEGFA165 is the dominant isoform in embryos, while VEGFA121 is the 
dominant isoform in adult tissues, indicating possible functional differences between these 




VEGFC induces mitogenesis, migration and survival of endothelial cells. It has long 
N- and C-terminal extensions as does VEGFD, which the other family members lack. VEGFC 
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shows similarities to VEGFD concerning receptor specificities (Schena et al., 1998). VEGFC 
is produced as a precursor protein and is proteolytically activated in the extracellular space by 
proteases to generate a homodimeric protein with high affinity for both VEGFR-2 and 
VEGFR-3 (Otrock et al., 2007b). Several studies and knockout models suggest that VEGFC is 
primarily a lymphangiogenic growth factor, and its lymphangiogenic effects are mediated by 
VEGFR -3. However, the increase in blood vascular permeability induced by VEGFC is 
mediated by VEGFR-2 (Roy et al., 2006a). 
  The existence of a lymphatic system in teleosts (bone fish) has been a matter of debate 
for decades. It has been difficult to document the development of the lymphatic system due to 
lack of specific markers. Recently it has been shown in zebrafish (Danio rerio) the exsistence 
of a lymphatic system (Yaniv et al., 2006), and the development of these vessels depend on 
VEGFC and VEGFR-3 signalling (Kuchler et al., 2006). 
The promoter of the VEGFC gene has been found to contain putative NF-κB binding 
sites which suggests that NF-κB may be involved in inducing VEGFC transcription  
 
1.4.3 VEGFD 
VEGFD is present in most adult tissues, and it stimulates growth of vascular and 
lymphatic endothelial cells by signalling through the tyrosine kinase receptors. The mature 
form has been shown to bind and activate VEGFR-2 and VEGFR-3 in humans, while the 
mouse VEGFD only binds to VEGFR-3 (Roy et al., 2006b). Nonetheless, VEGFD may 
induce lymphatic vessel growth in adult life in response to pathological conditions (Otrock et 
al., 2007b). 
VEGFD is structurally 48% identical to VEGFC by virtue of the unique presence of 
N- and C-terminal extensions as mentioned earlier (Roy et al., 2006b). Recently it was shown 





Recently VEGFD has been cloned in zebrafish (Song et al., 2007). The VEGFD precursor 
protein contains long N-terminal propeptides and almost complete VEGF homology domain 
(VHD) region, while it lacks about 80 amino acid residues in the C-terminal. This is different 
from human and mouse VEGFD (Song et al., 2007). 
                                                                                                                                                  19 
  Introduction 
 
                                                                                                                                                  20 
 
 
1.5 Aims of this study 
The aims of this study was to examine the effect of hypoxia on the expression of the 
hypoxia regulated transcription factors HIF-1α, HIF-2α and FIH, and the angiogenesis 
stimulating factors of the VEGF family in the crucian carp. In addition, the effect of hypoxia 
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2 MATERIALS AND METHODS 
This thesis reports two different experiments; (1) quantification of the expression of 
genes involved in angiogenesis in normoxic and hypoxic crucian carp brain, and (2) 
quantification of vascularisation in normoxic and hypoxic crucian carp brain.  
 
2.1 Animal handling 
Crucian carps were captured in Tjernsrud pond in Bærum, Norway, in August 2006.  
Fishes were kept in 750-litre tanks in the aquarium facility of the Department of Molecular 
Biosciences, University of Oslo. These tanks were continously supplied with aerated and 
dechlorinated tap water from Maridalsvannet, Oslo. A light/dark-cycle of 12h light/12h 
darkness was held, and the fish were fed daily with commercial fish food (Tetrapond, Tetra). 
They were not fed during experiments. Experimental animals weighed 33.2 ± 12 g (first 
experiment) and 29.0 ± 17 g (second experiment). Male/female fishes were randomly 
selected.  
Two experiments were performed, one in October 2006 for studying gene expression, 
and one in February 2007 to study vascularisation.  
 
2.2 Hypoxia exposure and tissue sampling 
Hypoxia exposures were performed at 9°C, with three exposure regimes; 10 days 
normoxia (N10), 10 days hypoxia (H10), and 10 days hypoxia followed by 10 days normoxia 
(H10N10). The experiments were performed in 25-litre circular tanks, with 23 fish in each 
tank. These tanks were supplied with dechlorinated tap water. De-oxygenation was obtained 
by N2-bubbling, and oxygen levels were monitored using two galvanometric oxygen 
electrodes connected to a computer (figure 2.1). 
Prior to the exposure, fishes were left to acclimate in the 25-litre tanks for 24 hours, followed 
by removal of excrements and closure of tanks with tight lids.  
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Figure 2.1.  Experimental set-up. Left circular tank represents normoxia experiment,  
 while right tank represents hypoxia experiment. The oxygen level and temperature were  
 registered by oxygen electrodes, and recorded by a computer.   
 
Fishes were killed by stunning them with a sharp blow to the head, before cutting the 
spinal cord and dorsal aorta, and removing the brain. Within 30 s of capture, brains were 
removed, and snap-frozen in liquid N2. The brains were stored at -80ºC.  
For the immunohistochemical experiment, the brains were cut in half between optic 
tectum and cerebellum and fixed in 4% phosphate buffered formalin (pH 7) (table 2.1) 
 
Table 2.1. Number of fish in each exposure group 
Time of 
exposure Temp ( °C) 
state of oxygenation and days of 
exposure (=n) organ Purpose 
October 2006 9 N10 (6) H10 6) H10N10 (6) brain gene expression
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2.3 Isolation of total RNA with TRIzol® Reagent 
The dissected brains were weighed in frozen condition (108.1 ± 23.1 mg) and quickly 
transferred to a tube placed on ice, containing 500 µl TRIzol (Invitrogen, Carlsbad, CA, 
USA). Total RNA from brain tissue was isolated according to the manufacturer`s protocol 
(Invitrogen, Carlsbad, CA, USA). An electrical homogenizer (Ultra-Turrax T8, IKA) was 
used to homogenize the brain tissue. 
 
2.4 Quality check of total RNA 
The quality of all total RNA samples were verified by analyzing 1 μl of 1:10 dilutions 
on a 2100 Bioanalyzer in accordance with manufacturer`s protocol (Agilent Technologies, 
Palo Alto, CA, USA). RNA concentrations were measured using a NanoDrop 
spectrophotometer (NanoDrop Technologies, Rockland, DE, USA). This was done using 1:10 
dilutions of total RNA. Duplicate measurements were performed, and the concentrations were 
found to be between 540-2500 ng/μl of undiluted total RNA solution. 28S/18S ratios were 
obtained, but as these are not reliable for quality control of RNA, all inspections of RNA 
integrity were performed visually (as recommended by Agilent Technologies). This was done 
by inspection of small and large peaks (such as rRNA and 28S RNA), and comparing peak 
shapes and assessing baseline flatness. No RNA samples were excluded at this stage.  
  
2.5 DNase treatment and cDNA synthesis 
1 μg of total RNA was treated with DNase Ι (DNA-freeTM Kit, Ambion Applied 
Biosystems, Foster City, CA, USA) prior to cDNA synthesis to avoid any possible 
contamination of genomic DNA. The DNase enzyme was inactivated, and the supernatant 
transferred to new tubes. 
Reverse transcription was performed using Superscript TM ΙΙΙ Reverse Transcriptase  
(Invitrogen, Carlsbad, CA, USA) and 500 ng oligo(dT)18. Both DNase Ι and cDNA synthesis 
were performed according to the manufacturer`s protocol. Two cDNA syntheses were carried 
out for each RNA sample. The cDNA was diluted 1:25 with DEPC (diethylpyrocarbonate)-
milliQ water. All procedures were performed according to manufacturer`s protocol.  
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2.6 Partial cloning and sequencing of the genes 
The genes of interest had not been sequenced in crucian carp prior to this study. It was 
therefore necessary to partially clone and sequence these to be able to design species specific 
primers for the real time RT-PCR assay. The following genes were cloned; VEGFA, VEGFC 
and VEGFD. 
Cloning was performed from cDNA of normoxic crucian carp brain tissue. The 
primers were designed in conserved regions of the genes. These regions were located using 
alignments of multiple organisms, mouse (Mus musculus), chicken (Gallus gallus), frog 
(Xenopus laevis), and pufferfish (Tetraodon nigroviridis/Takafugu rubripes), with emphasis 
on zebrafish (Danio rerio). The sequences were available on NCBI`s nucleotide database 
(http://www.ncbi.nlm.nih.gov/), and alignments were done using Clustal X (version 1.83) and 
Genedoc (version 2.6.002). Primers were designed using the web-based Primer3 software, 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and were synthezised by 
Invitrogen (Invitrogen, Carlsbad, CA, USA). All primers had a melting temperature around 
60°C. See table 2.2 for primer sequences. 
PCR was performed on 1:25 dilutions of the resulting cDNA using Platinum Taq 
polymerase (Invitrogen, Carlsbad, CA, USA). The following PCR program was used: 94°C 
for 10 min, 94°C for 30 sec, 50°C for 1 min, 72°C for 1 min, repeats steps 2-4 45×, 72°C for 
10 min, hold 4°C.  
PCR-reactions were analyzed by electrophoresis on 1 % agarose-gel containing EtBr 
(BHD-electron). Resulting dsDNA fragments were ligated into pGEM® -T easy Vector 
System Ι (Promega, Madison, WI, USA). Ligation reactions were transformed into CACl2-
compentent cells (TOP10 F; Invitrogen, Carlsbad, CA, USA), and afterwards applied on 
IPTG/X-gal agar plates. Colony PCR were performed on 6-8 colonies, using M13 forward 
and M13 reverse primers (Invitrogen, Carlsbad, CA, USA). Selection was based on the colour 
of the colonies. White colonies were picked because they had the desired insert, while blue 
colonies did not have this. Sequencing of the colony PCR-product was done using T7 primers 
at the ABI-lab at CEES, Department of Biology and Molecular Biosciences, University of 
Oslo, according to manufacturer`s protocol.  
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 Table 2.2. Primers used in initial gene fragment cloning 
Gene Forward primer 5` → 3` Reverse primer 5` → 3` 
VEGFA F1R1  GGCTCTCCTCCATCTGTCTG  TGCATTCACACTTGGTGTGTT 
VEGFC F2R2  TTGGGGCTACAAACACCTTC  TCTCTTGGGGTCCACGTTAC 
VEGFD F2R2  TGGACTTCACATGTTGCTTCTC  TCGCTCTACATCCATCTCACA 
 
 
2.7 Obtaining the 3′ end of VEGFA 
Variable splice cassettes of VEGFA are located at the 3′ end of this gene. The isoform 
VEGFA165  is of special interest, because an inhibitory variant, VEGFA165b has been 
identified in mammals (Woolard et al., 2004). Two different approaches were performed to 
obtain sequences from the VEGFA 3′ end. The two methods used were RACE and PCR to 
obtain expressed sequence tag (EST). 
 
2.7.1 Obtaining complete cDNA sequences by RACE 
RACE was performed on RACE cDNA from crucian carp brain (Cand. Scient. thesis 
by Dag Are Hov) using GeneRacerTM kit (Invitrogen, Carlsbad, CA, USA). GSPs were 
designed based on the previously described crucian carp EST (see section 2.6) using the 
Primer3 software. All GSP RACE primers are listed in table 2.3. 
 
Table 2.3. Primers used in RACE  
GENE Forward primer 5` → 3` Reverse primer 5` → 3` 
VEGFA RACE F1R1 TGTCCCTACAGAGACCCGCAACG GCTGTCAACGATACGCTACGTAACG 
VEGFA RACE F2R2 TGTGCAGGCTGCTGCAACGAC GCTGTCAACGATACGCTACGTAACG 
VEGFA RACE F3/ 
GeneracerTM 3′nested 
primer ACAGAGACCCGCAACGTCACC CGCTACGTAACGGCATGACAGTG 
VEGFA RACE F3/ nested 
primer 3 ACAGAGACCCGCAACGTCACC CGCTACGTAACGGCATGACAGTG 
VEGFA RACE nested 
primer 1/nested primer 3 TGTGCAGGCTGCTGCAACGAC CGCTACGTAACGGCATGACAGTG 
VEGFA RACE nested 
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The size of the 3′ RACE product was estimated to be 100-400 bp based on known 
zebra fish sequences. This information was used to set the length of the elongation step. The 
following PCR program was used: 94°C for 2 min, 94°C for 30 sec, 72°C for 1 min, repeat 
steps 2-3 5×, 94°C for 30 sec, 70°C for 1 min, repeat steps 4-5 5×, 94°C for 30 sec, 68°C for 
30 sec, 72°C for 1min, repeat steps 6-8 35×, 72°C for 10 min, hold 4°C. Nested RACE was 
performed using the following PCR program; 94°C for 2 min, 94°C for 30 sec, 72°C for 1 
min, repeat steps 2-3 5×, 94°C for 30 sec, 70°C for 1 min, repeat steps 4-5 5×, 94°C for 30 
sec, 68°C for 30 sec, 72°C for 1min, repeat steps 6-8 35×, 72°C for 10 min, hold 4°C. Cloning 
and sequencing of all RACE products were performed as described in section 2.6. RACE 
were performed according to manufacturer`s protocol. 
 
2.7.2 Obtaining VEGFA165 by PCR  
The crucian carp VEGFA165 splice variant was also targeted by using PCR. This 
implied cloning of an EST from the 3′ end using primers based on the previously described 
crucian carp VEGFA EST (section 2.6), and reverse primers from zebrafish. Primers are listed 
in table 2.4. 
 
Table 2.4. Primers used in VEGFA165 cloning 
Gene Forward primer 5` → 3` Reverse primer 5` → 3` 
VEGFA165 F1R1 ACTGCGAGTCAAACAACGTG GCTTTGACTTCTGCCTTTGG 
VEGFA165 F3R1 AAGGGATGAAGGGCAAAAAT GCTTTGACTTCTGCCTTTGG 
VEGFA165 F3R3 AAGGGATGAAGGGCAAAAAT
 
TCTTGGCTTTTCACATCTGC   
 
 
PCR, cloning and sequencing were performed as described in section 2.6. The 
following PCR program was used; 94°C for 2 min, 94°C for 30 sec, 72°C for 1 min, 72°C for 
2 min repeat steps 2-4 4×, 94°C for 30 sec, 68°C for 1 min, 72°C for 2 min repeat steps 5-7 
4×, 94°C for 30 sec, 65°C for 1 min, 72°C for 2 min, repeat steps 8-10 29×, 72°C for 10 min, 
hold 4°C.  
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2.8 Quantification of mRNA expression with real-time RT-PCR   
Designing primers for real time RT-PCR 
β-actin was chosen as internal RNA reference gene based on previous testing of the 
expression levels in the crucian carp brain under oxidative stress (Ellefsen S. et al., In prep.). 
Gene specific real-time RT-PCR primers were designed from crucian carp sequences using 
the LightCycler Probe Design Software (version 1.0, Roche). Primers were made for VEGFA, 
VEGFC and VEGFD, and synthesized by Invitrogen (Invitrogen, Carlsbad, CA, USA).  
Three primer pairs were designed for each of the genes of interest. These were tested 
in a real-time RT-PCR assay with cDNA. The specificity of the primers was verified by 




Table 2.5. Primers used for real-time RT-PCR  
Gene Forward primer 5` → 3` Reverse primer 5` → 3` 
β-actin TGTTTGAGACCTTCAACAC CGGACAATTTCTCTTTCG 










HIF-2α GTGGATTCAAAGAGCCT ATAGAACTCATACGCCGA 
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RNA extraction and cDNA synthesis for real-time RT-PCR   
Total RNA for real-time RT-PCR experiments was extracted from 65 mg brain tissue 
(9°C) of crucian carp (Table 2.1) using TRIzol® reagent. The amount of tissue being extracted 
was determined by the smallest available tissue sample in each experiment. This was achieved 
by using equal amounts of specific volumes of homogenized TRIzol/tissue mixtures (Ellefsen 
S. et al., In prep.). The aim was to maximize the amounts of extracted RNA and to 
standardize the procedure. Samples within one series of RNA extraction were handled in a 
particular order. The handling of each exposure group (N10, H10 and H10N10) shifted 
continuously. Within each exposure group individual fish were handled at random. The 




Quantification of mRNA levels of the genes of interest (see table 2.4) was performed 
on a Lightcycler® 2.0 instrument, using the LightCycler FastStart DNA MasterPLUS SYBR 
green Ι kit (Roche Diagnostics, Basel, Switzerland). Two real-time RT-PCR reactions were 
performed on each gene for each cDNA synthesis to quantify the expression of each gene. 
Since two cDNA syntheses were carried out for each RNA sample, a total of four real-time 
RT-PCR reactions were carried out on each gene for each cDNA synthesis. 
One adjustment was made; each reaction was halved as described in (Nolan et al., 
2006). The following real-time RT-PCR program was used; 94°C for 10 min, 94°C for 10 sec, 
60°C for 12 sec, 72°C for 8 sec, repeats steps 2-4 39×. A melting curve analysis was 
generated according to the manufacturer`s protocol. A melting curve is used to indicate that 
the PCR reactions contain only one type of PCR product. Melting curves are a powerful mean 
of providing accurate identification of amplified products and excluding them from primer 
dimers and other small artefacts (Nolan et al., 2006). 
 LightCycler PCR for target and reference genes was always run in the same carousel 
to avoid inter-assay variations. Real-time RT-PCR was performed according to the 
manufacturer′ s protocol (Roche Diagnostics, Basel, Switzerland). 
Data from the LightCycler PCR was visualized in the LightCycler3 Data Analysis 
program (Roche Diagnostics, Basel, Switzerland). Relative gene expression data were 
obtained from real-time RT-PCR raw-data using this equation:  
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actin- ββ =× 
 
 
where Tar = target gene, Con = control gene, E = priming efficiency and Cp = crossing point 
(Ellefsen S. et al., In prep.). 
The crossing point (Cp) was calculated by using the second derivative maximum 
method (LightCycler Software version 3.5, Roche diagnostics). Cp is a reference point in the 
PCR reaction curve to correlate the reaction curves to amount of initial starting template. The 
efficiency (E) was estimated for each PCR reaction using LinRegPCR (version 7.5) 
(Ramakers et al., 2003). Emeans was calculated for each real-time RT-PCR primer pair, and 
were used in calculations of relative gene expression.  
 
2.9 Statistical analyses 
The data obtained were tested for normality by the method of Kolmogorov and 
Smirnov. To test for significant changes in gene expression compared to the control (N10), 
the two way ANOVA was used. When the data showed significant variation in SD, two ways 
ANOVA with Tukey post Hoc test was used. P ≤ 0.05 was considered significant. The 
statistical calculations were done using GraphPad InStat (GraphPad InStat 3.06, GraphPad 









2.10 Immunohistochemical visualisation and quantification of blood vessels 
After 48 h of fixation, the tissue was placed in a Tissue-Tek VIP Vacum Infiltrating 
Processor (Sakura Finetek, USA) for dehydration and paraffin infiltration.  
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5 μm transverse sections from the telencephalon (Figure 2.2) were made on a Leica 
serial cutting machine. Sections were mounted on Menzel gläser SuperFrost (R) Plus (Menzel 
GmbH & Co KG, Saarbrückener Str. 248, Germany). Sections were placed in an incubator at 
approximately 58°C for 24 h. The purpose was to make the tissue stick to the glasses to avoid 
destroying epitopes: the temperature should not be higher than the melting point of the 






Figure 2.2. Schematic drawing of the common carp, Cyprinus carpio brain.( TEL; telencephalon, OT; optic 
tectum, CER; cerebellum, VL; vagal lobe (Echteler, 1984). 
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2.12 Laminin 
The basement membrane is a structure that supports overlying endothelial cells. It 
forms a continous sleeve around the endothelial tube in adult tissue, and the interaction of 
endothelial cells with basement membrane components plays an important role in the 
maintenance of vessel wall intergrity. The basement membrane of endothelium is composed 
of laminins (Hallmann et al., 2005). The members of the laminin family of glycoproteins are 
major constituents of basement membranes (basal lamina) and they are extracellular matrices 
in dense contact with individual cells and cell layers (Colognato and Yurchenco, 2000).  
 
2.12.1 Staining  
To select the appropriate method for detecting the vessels in the brain of the fish, 
different trial stainings were done; Hematoxylin/Eosin, PAS, Elastin van Gieson and Masson 
Trichrome. The vessels were stained, but for an untrained person it was difficult to count and 
measure them. Then different specific antibodies were tested, such as CD31, CD34 and Factor 
VIII with no result. The reason could be that these markers are for human tissue and not for 
fish. Anti-Laminin, one produced against human and different animals and one just against 
human were tested . Both of them gave the same good results, and Polyclonal Rabbit Anti-
Laminin from Dako was preferred due to its low price. 
Sections were deparaffinized in xylene, rehydrated through graded alcohol to distilled 
water. For target retrieval Dako Proteinase K (S2019, 40x) was used at room temperature for 
5  minutes. Endogenous peroxidase activity was blocked with 0.03 % Dako hydrogen 
peroxidase (Dako, S2001) for 5 minutes. Sections were incubated with primary antibody 
(Ab); Polyclonal Rabbit Anti-Laminin 1:400 (Dako, Z0097) for 1 hour in a humidity chamber. 
The antibody was diluted in Dako Antibody Diluent (Dako, S0809). The primary antibody 
was followed by a spine molecule (EnVision+ System, Dako, K4011) which contains 
molecules of secondary antibodies (anti-rabbit) and molecules of horesradish peroxidase 
(HRP) for 30 minutes. After each step sections were washed twice (2x5 minutes) in Tris-
buffered saline (TBS) pH 7.6. Development with 3.3´diaminobenzidine (DAB+, Dako, 
K3468) in buffered substrate solution containing hydrogene peroxide (H2O2) was performed 
for 12 minutes. Sections were counterstained with hematoxylin (Dako, S3301) for 3 minutes 
(Figure 2.3). After dehydration xylene sections were mounted with Eukitt (O. Kindler GmbH 
& Co, Germany).  
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As negative controls, staining with isotype and concentration matched controls were 
performed to ensure specific staining (rat Immunoglobulin fractions, DAKO, Denmark). 
Tonsillar tissue was used as positive control as recommended from Dako.  
 
 
Figure 2.3. For staining of one tissue marker by EnVision+ System. Primary antibody (step 1),  anti-Laminin,  is 
followed by a spine molecule  which contains  an average of 20 molecules of secondary  specific antibodies and 
100 molecules of Horseradish Peroxidase (HRP) enzymes (step 2). It is concluded with the use of substrate-
chromogen Diaminobenzine (DAB) + H2O2  reacting with the HRP enzymes on the spine molecule and  staining 
the positive laminin  vessels (step 3). The drawing is modified from Dako Handbook in Immunochemical staining 
methods, 3rd edition. 
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2.12.2 Stereology 
Five or six random sections taken from the telencephalon rostrally to the anterior 
comissure from each animal were investigated using a Zeiss Axioplan 2 imaging microscope. 
For one animal only 3 sections were investigated due to loss of sections. 2-4 no- overlapping 
photographs of resolution 2600 x 2060 pixles, corresponding to 680 x 539 µm, were taken 
from each section. Thus, a total area of 4398240-13194720 µm2 was analysed from each 
animal.  
 The images were analysed using ImageJ software (ImageJ 1.37v, 
(http://rsb.info.nih.gov/ij/), Wayne Rasband, National Institutes of health, USA). Two 
parameteres were measured according to methods described by Elias and Hyde (1980); blood 
vessel surface area per unit volume and blood vessel length per unit volume.  
Surface area was measured by superimposing test lines of known length randomly on 
the images, whereupon the number of times the lines were crossed by the surface of a stained 
profile was calculated. The resulting value, profiles per unit length of test line, (PL) was put 
into formula (1), taken from Elias and Hyde (1980), to obtain surface area per unit volume 
(SV). 
 
SV = 2PL        (1) 
 
 Vessel length was measured by superimposing test squares of known area randomly 
on the images and counting the number of stained vessels that were contained completely 
within the square or crossing the top or left sides of the squares. Vessels that crossed the right 
or bottom sides were excluded. The resulting value, number of profiles per investigated area 
(PA) was put into in formula (2), taken from Elias and Hyde (1980), to obtain vessel length 
per unit volume (LV). 
 
   LV = 2PA        (2) 
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2.13 Statistical analyses 
Fish weight and histological data were analysed by two-way ANOVA with sex and 
treatment (normoxia, hypoxia, hypoxia-normoxia) as independent variables, followed by 
Tukey-Kramer post-hoc test for unequal n. Correlations between dependent variables (weight, 
Sv, Lv) were analysed by linear regression. The difference between regression slopes were 
compared using the t statistics according to the method suggested by Armitage (1980) There 
was no significant deviation from normality (Komogorov-Smirnov test) or lack of 
homogeneity of variance (Levene's test) for any dependent variable. Chi-square test 
confirmed that the frequency of males and females in each experimental group did not differ 
significantly between groups. 
 
 
  Results 
 
3 Results 
The exposure groups are here abbreviated as N10 (normoxia 10 days), H10 (hypoxia 
10 days) and H10N10 (hypoxia 10 days followed by normoxia for 10 days). 
 
3.1 Cloning and sequencing of VEGFA, VEGFC and VEGFD  
The phylogenetic tree shown in figure 3.1 presents the obtained crucian carp (cc) 
sequences for VEGFA, VEGFC and VEGFD groups together with previously described 
sequences from zebrafish (dr).  
 
Figure 3.1. Phylogenetic tree of VEGFA, VEGFB, VEGFC and VEGFD showing the relationsship between the 
genes in different species. Species included are cc = carassius carassius, dr = danio rerio, hs = homo sapiens 
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3.2 Relative mRNA levels of HIF-1α and HIF-2α 
Quantification of mRNA levels of the HIF genes were performed on total RNA from 
crucian carp brains exposed to different oxygen regimes at 9°C. Expression data of each gene 
was normalized using β-actin as the internal reference gene. 
No significant changes in expression were detected in either HIF-1α (Two way 
ANOVA, P = 0.06) or in HIF-2α (Two way ANOVA, P =0.70) in H10 compared to the N10 









Figure 3.2. Relative mRNA levels of HIF-1α and HIF-2α in the crucian carp brain, exposed to different oxygen 
regimes at 9°C. The data is normalized using β-actin as the internal reference gene. For number of fish in each 
exposure group, see table 2.1. For statistical details, se appendix ΙΙ. 
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3.3 Relative mRNA levels of FIH-1 
Quantification of mRNA levels of the FIH-1 gene was performed on total RNA from 
crucian carp brains exposed to different oxygen regimes at 9°C. Expression data of each gene 
was normalized using β-actin as the internal reference gene. 
  
 FIH-1 showed a significant increase in expression in H10 compared to the N10 group 
(Two way ANOVA, P = 0.002). Different letters denote significant differences (Tukey post 












Figure 3.3. Relative mRNA levels of FIH-1 in the crucian carp brain, exposed to different oxygen regimes at 
9°C. The data is normalized using β-actin as the internal reference gene. Different  letters denote significant 
differences (Tukey post hoc test).  For number of fish in each exposure group, see table 2.1. For statistical 
details, se appendix ΙΙ.. 
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3.4 Relative mRNA levels of the VEGF genes   
 Quantification of mRNA levels of the VEGF genes were performed on total 
RNA from crucian carp brains exposed to different oxygen regimes at 9°C. Expression data of 
each gene was normalized using β-actin as the internal reference gene. 
With regard to the VEGF genes, both VEGFA (Two way ANOVA, P< 0.01) and 
VEGFC (Two ways ANOVA, P = 0.005) showed a significant increase in H10 compared to 
N10. Different letters denote significant differences (Tukey post hoc test). There was no 
significant effect of sex (Two way ANOVA, VEGFA, P = 0.89, VEGFC, P = 0.13) (figure 
3.4) in either VEGFA or VEGFC. No significant changes were detected in the expression of 
VEGFD compared to the N10 group, and no effect of sex in VEGFD was seen (Two way 




Figure 3.4. Relative mRNA levels of VEGFA, VEGFC and VEGFD in the crucian carp brain, exposed to 
different oxygen regimes at 9°C. The data is normalized using β-actin as the internal reference gene. Different 
letters denote significant differences (Tukey post hoc test). For number of fish in each exposure group, see table 
2.1. For statistical details, se appendix ΙΙ. 
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Figure 3.5. Relative composition of VEGFA, VEGFC and VEGFD  mRNA in normoxic, hypoxic and hypoxic 
normoxic crucian carp brain.  
 
3.5 Full length sequence of the VEGFA gene 
Two different approaches were performed to obtain sequences from the VEGFA 3′ 
end. The first strategy was to perform RACE, which provided 20 sequences similar to the 
zebrafish VEGFA121 variant, while it provided no sequences similar to VEGFA165. Moreover, 
the obtained VEGFA121 sequence displayed a curious property, its CDS (coding domain 
sequence) was not being defined by a stop codon. Since RACE failed to provide the 
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Figure 3.6. Bloodvessels stained for Laminin 
 
From the second experiment, 20 fishes were used for immunohistochemical 
localisation of blood vessels. Of those fishes 8 had been exposed to 10 days of hypoxia, 6 to 
10 days of hypoxia followed by 10 days of normoxia and the control group consisting of 6 
animals that had been in normoxia for 10 days.  
The experimental material was homogenous with respect to body size, so that fish 
weight did not differ between experimental groups or between males and females (two way 
ANOVA, effect of sex, P = 0.69; treatment effect, P = 0.54; sex/group interaction, P = 0.91). 
The frequency of males and females did not differ significantly between groups (chi-square 
test, P>0.05). 
 Blood vessels were easily identified by a brown residue due to the DAB 
polymerisation reaction (figure 3.6). All stained structures were included in the calculation of 
surface area per volume (Sv) and length per volume (Lv) described in section 2.13  
The surface area per volume (Sv) was affected by both sex (P = 0.001) and 
experimental treatment (P < 0.001), and there was also significant interaction between the two 
variables (P = 0.009). Group means, S.E.M., and n are given in table 3.1. From this overview, 
it appears that males in general had lower Sv than females, with an overall mean (± S.E.M.) of 
0.0119 ± 0.0004 (mm2/mm3) and 0.0131 ± 0.0009 (mm2/mm3), for males and females 
respectively (P < 0.001). Compared to controls in normoxia (overall mean ± S.E.M. = 0.015 ± 
0.001), Sv was reduced in fish exposed to hypoxia (overall mean ± S.E.M. = 0.0112 ± 0.0004, 
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P < 0.001) as well as fish subjected to hypoxia followed by recovery in normoxia (overall 
mean ± S.E.M. = 0.0122 ± 0.0002, P < 0.001). 
 
Table 3.1. Blood vessel surface area per volume (Sv) of crucian carp telencephali after 10 days of normoxia, 10 
days of hypoxia and 10 days of hypoxia followed by 10 days of reoxygenation in males, females and combined 
groups. Post-hoc tests for subgroups identified by both sex and treatment were not performed due to low 
numbers of individuals in the groups.  
 Sv mean 
(mm2/mm3) 
S.E.M. n 
N10 0,0148 0,0011 5 
      males 0,0131 0,0005 3 
      females 0,0174 0,0008 2 
H10 0,0112 0,0004 9 
      males 0,0102 0,0005 3 
      females 0,0118 0,0004 6 
H10N10 0,0122 0,0002 6 
      males 0,0122 0,0003 4 
      females  0,0122 0,0001 2 
 
 
The effect of exposure to hypoxia was also present for length per volume (Lv) (P < 
0.001), while the effect of sex was absent for this variable (P = 0.32). Accordingly data for 
males and females were pooled and the resulting averages are graphed in figure 3.2. Even for 
this variable the normoxia group was significantly different from the other groups, while the 
trend towards recovery in the reoxygenation group (H10N10) did not reach statistical 







































Figure 3.2. Length of the blood vessel system per volume (Lv) in the telencephali of crucian carp kept in 
normoxia or hypoxia for 10 days or hypoxia for 10 days followed by normoxia for 10 days (Means + S.E.M.). 
Asterisks indicate a significant difference to controls kept in normoxia (* P < 0.05, *** P < 0.001) 
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In figure 3.3 the regression between Lv and Sv is plotted with a common regression 
line for the three treatment groups. There were no between-group differences in regression 
line slopes (ANCOVA: N10 vs. H10: t(10) = 0.47, P = 0.65; H10 vs. H10N10: t(11) = 0.65, P = 
0.51; N10 vs. H10N10: t(7) = 0.29, P = 0.78). In pooled data this regression was highly 
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Figure 3.3. The relationship between the blood vessel length per volume (Lv) and blood vessel surface area per 









In the present study the following genes were cloned from crucian carp; VEGFA, 
VEGFC, VEGFD (figure 3.1), HIF-1α, HIF-2α and FIH-1. Hypoxia exposure resulted in 
significant increases in the mRNA levels of VEGFA and VEGFC, while no changes were 
observed in VEGFD mRNA. The expression of FIH increased significantly. No changes were 
observed in HIF-1α and HIF-2α expression, but a trend towards a reduction in hypoxia was 
seen in HIF-1α mRNA.  
With regard to vascular density in the telencephalon it was found that both surface 
area and total length of the blood vessel system were reduced in fish exposed to hypoxia.  
 
 
4.1 Effect of hypoxia on mRNA levels in HIF, FIH and VEGF 
While VEGF gene structure and regulation are less well characterized in fish 
compared to mammals, there are indications that these genes are also important for 
angiogenesis in fish. Thus VEGFA (Gong et al., 2004; Li et al., 2007), VEGFC (Roberts et 
al., 2004) and VEGFD (Song et al., 2007) have been cloned and characterized in zebrafish, 
where they appear to play important roles in vasculogenesis and angiogenesis. Previous 
results show that the expression of VEGF in mammals increases in hypoxia, and remain 
increased for an extended period (Kuo et al., 1999; Xue, 1998), but for how long depends on 
the species, hypoxia-protocol etc. 
VEGFA showed the highest level of expression among the VEGF genes. It increased 
6-fold in hypoxia and it constituted 90 % of the quantified VEGF expression in hypoxia 
(figure 3.5). The cDNA sequences of VEGFs obtained by cloning differed from VEGF in 
mammals, and even from other fish like zebrafish (figure 3.1). However, the deduced amino 
acid compositions of the VEGFs in crucian carp showed a high degree of similarity to those 
of zebrafish, suggesting that the functionalities of the VEGF genes are preserved.  
That VEGF cDNA sequences differ between species also apply to their splice 
isoforms. While at least six splice isoforms of VEGFA exist in mammals (Roy et al., 2006b), 
in zebrafish four splice isoforms have been identified so far. These are named VEGFA121, 
VEGFA165, VEGFA12345z 678 and VEGFA1234577a8. A variant similar to zebrafish VEGFA121 
was obtained in the crucian carp, and VEGFA165 was partially cloned in the crucian carp 
(appendix ΙV). Two different strategies were tested to get to these sequences. RACE was 
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performed to obtain the 3′ end of VEGFA where the splice cassette is. This resulted in short 
sequences, which were similar to zebrafish VEGFA121. However, these crucian carp 
VEGFA121 sequences appeared odd, because no stop codon was found. The second approach 
was to create a sequence based on the cloned crucian carp VEGFA sequence and the 3′ end of 
the VEGFA165 sequence from zebrafish (section 2.7.2), allowing partial cloning of VEGFA165 
in crucian carp. Gong et al. (2004) found in zebrafish that all tissues analyzed expressed high 
levels of VEGFA121 and VEGFA165. They identified two new variants, VEGFA12345z 678 and 
VEGFA1234577a8, where VEGFA12345z 678 was detected in heart and muscle while 
VEGFA1234577a8 was only detected in zebrafish heart. These findings indicate that the different 
splice isoforms are not expressed in all tissue. It could be that their expression is restricted to 
particular organs or cell types. Since it was difficult to clone the VEGFA165 variant in crucian 
carp brain, VEGFA165 may have very low expression levels in this organ. Gong et al. (2004) 
concluded in their study that the CDS of zebrafish VEGFA was highly conserved between 
teleosts and mammals, while no obvious conservation was seen in the 5′ flanking regions. 
This suggests possible differences in VEGF gene regulation between fish and mammals.  
The trend towards a reduction in VEGFD expression observed in hypoxia indicates 
that it does not have the same function in crucian carp as VEGFA and VEGFC. In humans 
VEGFD is both angiogenic and lymphangiogenic, while in mice it is proposed to be 
lymphangiogenic but not angiogenic due to the lack of a receptor (Baldwin et al., 2005). It has 
been shown in mice that expression of VEGFD induced growth of lymphatic vessels whereas 
blood vessels were unaffected (Veikkola et al., 2001). In addition, the zebrafish VEGFD gene 
is about 80 amino acids shorter than human and mouse VEGFD, and the crucian carp VEGFD 
was found to be even shorter, pointing at the possibility that crucian carp VEGFD has 
different functions than VEGFD in mammals.  
The expression level of HIF-1α showed a trend towards a reduction in hypoxia, 
though not significant. No significant changes were seen in HIF-2α either. Changes seen in 
mRNA levels of HIF-1α and HIF-2α should not be emphasized too much because hypoxia 
induced changes in these factors primarily depend on increased protein levels (section 1.3). In 
crucian carp gills, the highest amount of HIF-1α protein is seen after 6 h of hypoxia, while 
after 48 h of hypoxia the level of HIF-1α protein is no longer elevated (Sollid et al., 2006). 
Chavez et al. (2000) examined the effects of hypoxia on HIF-1α and VEGF in the rat brain 
(Chavez et al., 2000). They found that during hypoxia the levels of HIF-1α protein remained 
significantly elevated for at least 14 days, and that they returned to normoxic levels within 21 
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days. The increased HIF-1α levels were paralleled by increased VEGFA transcript levels, 
indicating that HIF-1α targets VEGFA. In addition, the VEGFA gene has an HRE in its 
promoter region which HIF-α binds to and up-regulate VEGF expression (Hirota and 
Semenza, 2006; Storkebaum et al., 2004). While it is well established that VEGFA is a target 
gene for HIF-1α, it is possible that VEGFA expression can be induced by other genes than 
HIF-1α.  
The expression levels of FIH increased 4-fold. FIH is known to reduce HIF-α 
transcriptional activity in normoxia, and Stolze et al. (2004) showed in mammalian cell lines 
that FIH contributes to control of HIF transcriptional response in hypoxia as well (Stolze et 
al., 2004). That both VEGFA and FIH increased in hypoxia in the present study might imply 
that the protein level of HIF-α also increases, due to negative feedback. Increased activity of 
FIH could start the process to reduce HIF-α activity. Obviously, protein levels of HIF-α have 
to be measured to verify that the expression of HIF-α increases in hypoxic crucian carp. 
 
4.2 Vascularization 
A decrease in both surface area and total length of the blood vessel system were seen 
in the present study. These findings are not in accordance with previous studies on the brain 
of mammals (e.g.(Dore-Duffy and La Manna, 2007; Drew et al., 2004; Harik et al., 1996; 
Harik et al., 1995; Mironov et al., 1994)), which show that hypoxia leads to angiogenesis with 
a near doubling of the capillary density (Dore-Duffy and La Manna, 2007). Xu and 
Severinghaus (1998) reported that the capillary density in rat brian increases significantly 
after one week of hypoxia, and a maximum increase reached after two weeks. Experiments in 
this field have mainly been performed on mice and rats, and to our knowledge no results are 
available from fish.  
One could argue that the reduced vessel density can be explained by brain swelling. 
However, Van der Linden et al. (2001) demonstrated that the crucian carp brain does not 
swell during anoxia.  
A possible explanation for the results in the present study is that there is no need to up-
regulate the amount of vessels. Prolonged hypoxia results in a CBF increase in crucian carp, 
which could counteract the effect of reduced blood oxygen levels on oxygen delivery (Nilsson 
et al., 1994).  
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Moreover, it could be that making new blood vessels is too energy demanding for the 
crucian carp during hypoxia, and it is possible that VEGF has other functions beside blood 
vessel formation. It has been shown that VEGF has a direct neuroprotective effect in rats 
(Silverman et al., 1999), and studies performed on primary cultures of mice neurons increased 
neuronal viability (Jin et al., 2000). 
The problem the crucian carp has to solve when it is exposed to hypoxia is to provide 
the tissue with enough oxygen. Vertebrates express HIF-α, and the function of this protein is 
to protect tissues from low oxygen levels. HIF-α is probably very important for local 
regulation of processes like angiogenesis, but a general increase in HIF-α levels, and all the 
pathways stimulated by it, could be undesirable for anoxia-tolerant animals exposed to 
general hypoxia. If angiogenesis (and erythropoiesis) is activated throughout the body, it 
could be that the hypoxic animal would end up as a “red ball” filled with blood and 
capillaries, wasting large quantities of energy building capillaries and erythrocytes and on 
pumping around an abnormally large blood volume. In view of this, it is tempting to suggest 
that there have to be mechanisms that inhibit HIF-α or HIF-α activated  processes when the 
crucian carp becomes hypoxic. The increase in FIH seen in the present study indicates that 
FIH could be part of a system aimed at blocking HIF-α effects in hypoxic crucian carp. If 
VEGFA is involved in angiogenesis in crucian carp there have to be more factors than FIH 
involved in blocking angiogenesis, because VEGFA levels did increase and VEGFA is 
downstream of FIH inhibition. 
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4.4 Conclusions 
Relative mRNA levels of VEGFA and VEGFC increased significantly in the crucian 
carp brain, while no changes were seen in VEGFD. VEGFA increased 6-fold and constitutes 
the largest part of the quantified VEGF expression. The VEGFA, VEGFC and VEGFD 
sequences obtained by cloning were different from VEGF in mammals, but similar to those of 
zebrafish. The crucian carp VEGFA splice isoforms were also similar to zebrafish VEGFA121 
and VEGFA165.  
The expression level of FIH increased 4-fold, while no significant changes in mRNA 
levels were seen in either HIF-1α or HIF-2α.  
A significant hypoxia-induced decrease in vessel density was seen. The increase in 
VEGFA expression along with a reduction in blood vessel density can indicate that the 
crucian carp does not need additional vessels in hypoxia. On the contrary, it is possible that  
HIF-α effects have to be actively counteracted. Thus while HIF-1α is likely to be important in 
regulating regional oxygen supply by activating processes like angiogenesis, it could have 
undesirable effects during global hypoxia. If HIF-1α is allowed to activate angiogenesis in all 
tissues during hypoxia, the hypoxic animal could end up with having to pay too high costs for 
cell proliferation and for pumping a greatly increased blood volume. Thus, a well adapted 
facultative anaerob like the crucian carp may activate mechanisms aimed at turning off     
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Reagents, equipement and software 
The following reagents, equipement and software were used in this thesis. 
 
Reagents (product, catalogue number and manufacturer) 
Advtantage 2 polymerase mix, Clontech Laboratories Inc., Mountain View, USA 
Agarose, SeaKem®, 50004, Cambrex 
Ampicillin (D[-]-α-Aminobenzylpenicillin), A-9518, Sigma 
Antibody Diluent, S0809, DakoCytomation 
Anti-Laminin 1.20, L9393, Sigma 
Anti-Laminin 1:400, Z0097, DakoCytomation 
Chloroform, C2432, Sigma 
DAB+, K3468, DakoCytomation 
DEPC (dietyl pyrokarbonat), SD5758, Sigma 
EnVision+ System, K4011, DakoCytomation 
Etidium bromide, 443922U, BHD-Electron 
Eukitt, O. Kindler GmbH & co., Germany 
FastStart Taq Polymerase, 03515885001, Roche Diagnostics  
GeneracerTM Kit, version L, Invitrogen 
Haematoxylin, S3301, DakoCytomation 
Hydrogen peroxide 0.03%, S2001, DakoCytomation  
LightCycler®FastStart DNA MasterPLUS SYBR Green Ι, 03515885001, Roche Diagnostics  
Menzel gläser SuperFrost (R) Plus, Menzel GmbH & Co KG, Saarbrückener Str. 248, 
Germany 
pGEM®-T Easy Vector Systems, A1360, Promega 
Proteinase K 40x, S2019, DakoCytomation 
RNA 6000 Nano Lab Chip® Kit, 5065-4474, Agilent  
RNA 6000 Nano Reagents PartΙ, 5067-1511, Agilent 
SOC medium, 15544-034, Invitrogen 
SuperscriptTM ΙΙΙ Reverse Transcriptase, 18080-(044), Invitrogen 
T7 RNA Polymerase, 18033-019, Invitrogen 
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TRIzol® Reagent, 15596-018, Invitrogen 
TURBO DNA-freeTM Kit, Cat #1907, Ambion 
X-Gal, V3941, Promega 
 
Equipment (product, catalogue number/model and manufacturer) 
Agilent Bioanalyzer, G2938B, Agilent 
BioDoc-ItTM System, UVP  
Eppendorf centrifuge, 5417R, Eppendorf 
Finnpipettes, U23386, T27033, T27388, T28301, Thermo Labsystems 
Homogenizer, Duall® 22, Kontes glass 
Homogenizer, Ultra-Turrax T8, IKA 
LightCycler Capillaries (20 μl), 11909339001, Roche Diagnostics 
LightCycler Carousel Centrifuge, 12189682001, Roche Diagnostics 
LightCycler 2.0 Instrument, 03531414201, Roche Diagnostics 




AxioVision, Release 4.5, Des 2005 
Bioanalyzer 2100 expert, version B.01.02 SΙΙ36, Agilent Technologies 
GraphPad InStat 3.06, GraphPad Software Inc.             
ImageJ 1.37v, (http://rsb.info.nih.gov/ij/), Wayne Rasband, National Institutes of health, USA 
LightCycler3 Data Analysis, version 3.5.28, Idaho Technology Inc. 
LightCycler3 Front, version 3.5.17, Idaho Technology Inc. 
LightCycler3 Probe Software, version 1.0, Idaho Technology Inc. 
LightCycler3 Run, version 5.32, Idaho Technology Inc/ Roche Diagnostics 
NanoDrop 3.0.1, Coleman Technologies Inc. 
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BioEdit Sequence alignment editor, version 
 (http://www.mbio.ncsu.edu/BioEdit/page2.html), © 1997-2005 by Tom Hall 
Clustal X, version 1.83, Feb 2003 (ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX/)  
GeneDoc, version 2.6.002 (http://www.psc.edu/biomed/genedoc/) © 2000 by Karl Nicholas 
GENSCAN (http://genes.mit.edu/GENSCAN.html) © 1997-2005 by Christopher Burge 
LinReg, version 7.5, Feb 2004 (Available on request; e-mail; bioinfo@amc.uva.nl; subject:  
 LinReg PCR), Dr. J. M. Ruijter, Department og Anatomy and Embryology, Academic  
 Medical Centre, Amsterdam, Netherlands 
Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi), © 2004 Whitehead  
 Institute for Biomedical Research 
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Statistical details of each gene of interest. The reference explains where in this thesis a 





Test P-value Post-test n in each group 
(N10,H10,H10N10) 
Reference 
HIF-1α Two way 
ANOVA 
0.06  6, 5, 6  Figure 3.1 
HIF-2α Two way 
ANOVA 
0.70  6, 5, 6  Figure 3.1 
FIH-1 Two way 
ANOVA 
0.002 Tukey post 
Hoc test 
6, 5, 5  Figure 3.3 
VEGFA Two way 
ANOVA 
< 0.01 Tukey post 
Hoc test 
6, 5, 5 Figure 3.4 
VEGFC Two way 
ANOVA 
0.005 Tukey post 
Hoc test 
6, 5, 5 Figure3.4 
VEGFD Two way 
 ANOVA 
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The following sequences of crucian carp (Cc) were obtained by cloning and 




Cc_VEGFA_303bp                                              real-time RT-PCR product: 145-301 
  1   CTGTTAAGGCTGCCCACATACCTAAAGAAGGGATGAAGGGCAAAAA      46  
 47   TGAGGTGATTCCCTTCATGGATGTGTACAAAAAGAGTGCATGTAAGA    93 
 94   CGCGAGAGTTGCTGGTAGACATCATTCAGGAGTATCCTGACGAGATC  140 
141  GAGCACACCTACATCCCGTCCTGTGTGGTTCTCATGCGCTGTGCAGG    187 
188  CTGCTGCAACGACGAAGCACTCGAGTGTGTCCCTACAGAGACCCGCA  234 
135  ACGTCACCATGGAGGTACTGCGAGTCAAACAACGTGTTTCGCAGCAT   281  





Cc_VEGFC_682bp                                                 real-time RT-PCR product: 43-297                 
1       TATAAACCACCCTGCGTGTCTGTCTACAGATGTGGGGGCTGCTGTAA       47 
48    CAGTGAGGAGCAAGTGTGCAAGAACATGAGCACTTCATACGTCAGTA      94 
95     AGACGTTGTTTGAAATCACAGTTCCTATGAAGTATGGGCCCAAGCCA      141 
142   GTCACCATAAGCTTCGCCAACCACACTTCCTGCAGCTGTTTGTCAAAA     189 
190   CAGGATTTGTACCGACAGCAGCACTCAATAATTCGAAGGGCCTTACC      236 
237   AGAATGTCATGTGGCAAATAAAACATGCCCAAAGAATCACAGCTGGA    283 
284   GTAATCGCTTGTGTAGATGTGTGCCACTACCCGACACCCTCTTTTCACA   332 
333   GCCAAATTATGCAGACTTTGAGCAGGACTTCTGCGGTCCCGACAAAGA   380 
381   GCTGGATGAAGAGACTTGTCAGTGTGTATGCCGAAAACAGCTGCGAAC  428 
429   GGCAGGCTGTGGACCGCACCACTATTTGGACAAGAACACCTGTCAGTG   476 
477   TGTGTGTAAAGCGAAGCCTTCTTCCTGCAGGCCTCAACAGAGCTTCAA    524 
525   CAAGGACACCTGCCATTGCACCTGCACCAAGGTGTGTCCTAGCAGTCA   572 
573   GCCTCTCAACCGCACCAAATGTGTGTGTGAATGCACAGAGTCCCCTAA    620 
621   CAAGTGCTTCTTAAAAGGAAGGCGGTTCCACCCGGGCACATGCAGTTG   668 
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Cc_VEGFD_705bp                                              real-time RT-PCR product: 377-636  
1   CTGTATGTCAGATTGATGCTGGCCGTGGACGCCTACAGACCCCAGAGA       48 
49  GACATAAACCAGGAGAGGTGGGAACAGGAAATAAGGGAAGCTGGGAG     95 
96   TCTGGATGAGCTTATGATGTTGACCGAATACCCGGACTGGAAGCTGKG     143 
144 GAGATGCAGATTTAAGCTGAAGCACTTTGAATATGTCAATCCGCTTGAG   192 
193  AACCGCAGGTCAACACGCTATGCTGCCACATCATTCAGCCCAGAGATTC  241 
242  TTAAAGATATTGATGACGAATGGCAGAAAACACAGTGTATGCCCAGAGA 290 
291  GACATGTGTAGATGTGGCTAAAGAGCTGGGCACCAGTACGGCTGTGTTC  339 
340  TTTAAGCCCCCGKGTGTCTCTGTCTTCAGGTGTGGCGGCTGCTGCAACAA  389 
390  AGAGGGAGTTACCTGCCGTAATACAAGCGTGACTTATATTAATAAAACT   438 
439  ATTTTGAGTGTGAGTCTGGCTCCGTATAAATCTGGACCAGAGCCCGTGCT 488 
489  GGTGAAAATTGCCAATCACACTGAGTGCATGTGCCAGGAACATACGCTG  537 
538  ATTCGCAGACATGTTCGTGAGAAGCACAAGAAGAGTTGCTCTCCTACAC   586 
587  GTAAGCCAGAAGACAAGAGGCTATGCAACAGAGGTTTAATATGGGACT    634 
635  GGATGGCGGAGCGATGTGTGACGTACCCCTCCAGTAAACAAGATCCTCC  683 
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VEGFA121 and VEGFA165 
An amino acid alignment showing the human (hs) VEGFA121 and VEGFA165 
sequences and comparing them to analogous sequences from zebrafish (dr) and crucian carp 
(cc). Complete CDS are shown for hs and dr. In all sequences but the hs VEGFA165 dots refer 
to conserved amino acid sequences, letters refer to differences in amino acids and hyphens 
refer to the lack of amino acids. The question marks refer to uncharacterized amino acids in 
the crucian carp sequences.  
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The procedure in the machine is as followed: 
 
1. The tissue was first dehydrated; defined as replacment of water by hydrofobic liquids. 
This was done by using an increasing alcohol concentration, from 70% until absolute 
alcohol. The time should be as short as possible to avoid shrinkage (average time 
about five and a half hour; 70% alc 30 minutes, 96% alc 1 hour, Abs alc 4 times 1 
hour).   
2. The alcohol is then replaced by a clarifying agent, xylene, which is soluble both in 
alcohol and paraffin (two times 1 hour). 
3. Xylene is replaced by liquid paraffin which has a melting point at about 60 degrees (4 
times 45 minutes). 
 
These three steps are done in the machine under pressure and high degree to decrease the 
penetrating time and to get a good infiltration of the paraffin. 
 
